1 – 27 of 27
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Similar immune responses to alpha1-oleate and Bacillus Calmette–Guérin treatment in patients with bladder cancer
(
- Contribution to journal › Article
-
Mark
BAMLET administration via drinking water inhibits intestinal tumor development and promotes long-term health
(
- Contribution to journal › Article
-
Mark
Therapeutic Effects of IL-1RA against Acute Bacterial Infections, including Antibiotic-Resistant Strains
(
- Contribution to journal › Article
-
Mark
Genetic determinants of renal scarring in children with febrile UTI
2024) In Pediatric Nephrology(
- Contribution to journal › Article
- 2023
-
Mark
Sustained delivery of a heterodimer bone morphogenetic protein-2/7 via a collagen hydroxyapatite scaffold accelerates and improves critical femoral defect healing
(
- Contribution to journal › Article
-
Mark
Long-term prevention of bladder cancer progression by alpha1-oleate alone or in combination with chemotherapy
(
- Contribution to journal › Article
- 2022
-
Mark
Immunomodulation therapy offers new molecular strategies to treat UTI
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Collateral effects of deletion of nlpD on rpoS and rpoS-dependent genes. Reply.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Active bacterial modification of the host environment through RNA polymerase II inhibition
(
- Contribution to journal › Article
-
Mark
A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancer
(
- Contribution to journal › Article
-
Mark
A scientific journey from discovery to validation of efficacy in cancer patients : HAMLET and alpha1-oleate
(
- Contribution to journal › Article
-
Mark
Immunomodulation—A Molecular Solution to Treating Patients with Severe Bladder Pain Syndrome?
(
- Contribution to journal › Article
-
Mark
Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex
(
- Contribution to journal › Article
-
Mark
Molecular determinants of disease severity in urinary tract infection
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Bladder cancer therapy without toxicity—A dose-escalation study of alpha1-oleate
(
- Contribution to journal › Article
- 2019
-
Mark
Molecular determinants of disease severity in urinary tract infection
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Fimbriae reprogram host gene expression - Divergent effects of P and type 1 fimbriae
(
- Contribution to journal › Article
- 2018
-
Mark
Neuroepithelial control of mucosal inflammation in acute cystitis
(
- Contribution to journal › Article
- 2016
-
Mark
Urinary Tract Infection Molecular Mechanisms and Clinical Translation.
(
- Contribution to journal › Scientific review
-
Mark
Bacterial suppression of RNA polymerase II-dependent host gene expression
(
- Contribution to journal › Scientific review
-
Mark
Susceptibility to urinary tract infection : Benefits and hazards of the antibacterial host response
(
- Contribution to journal › Scientific review
-
Mark
IRF7 inhibition prevents destructive innate immunity-A target for nonantibiotic therapy of bacterial infections
(
- Contribution to journal › Article
-
Mark
The Genetics of Urinary Tract Infections and the Innate Defense of the Kidney and Urinary tract
(
- Contribution to journal › Scientific review
-
Mark
Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets
(
- Contribution to journal › Article
- 2015
-
Mark
Innate immunity and genetic determinants of urinary tract infection susceptibility.
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Bacterial control of host gene expression through RNA polymerase II
(
- Contribution to journal › Article
-
Mark
Lipids as Tumoricidal Components of Human Alpha-lactalbumin Made Lethal to Tumor Cells (HAMLET); Unique and Shared Effects on Signaling and Death.
(
- Contribution to journal › Article